ロード中...
Angiogenesis inhibitors in clinical development; where are we now and where are we going?
Angiogenesis is crucial for tumour growth and the formation of metastases. Various classes of angiogenesis inhibitors that are each able to inhibit one of the various steps of this complex process can be distinguished. Results from clinical studies with these agents are summarised. In general, it ha...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2395335/ https://ncbi.nlm.nih.gov/pubmed/14710197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601401 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|